GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Tianyu Pharmaceutical Co Ltd (SZSE:300702) » Definitions » Pre-Tax Income

Zhejiang Tianyu Pharmaceutical Co (SZSE:300702) Pre-Tax Income : ¥115 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Tianyu Pharmaceutical Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Zhejiang Tianyu Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ¥96 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥115 Mil. Zhejiang Tianyu Pharmaceutical Co's pretax margin was 12.63%.

During the past 12 years, Zhejiang Tianyu Pharmaceutical Co's highest Pretax Margin was 32.41%. The lowest was -4.14%. And the median was 9.29%.


Zhejiang Tianyu Pharmaceutical Co Pre-Tax Income Historical Data

The historical data trend for Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Tianyu Pharmaceutical Co Pre-Tax Income Chart

Zhejiang Tianyu Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 768.88 218.41 -110.50 71.92 78.64

Zhejiang Tianyu Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.93 8.68 38.12 -28.09 95.93

Competitive Comparison of Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income falls into.


;
;

Zhejiang Tianyu Pharmaceutical Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Zhejiang Tianyu Pharmaceutical Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=168.737+0+-54.069+19.877+-55.907
=79

Zhejiang Tianyu Pharmaceutical Co's Pretax Income for the quarter that ended in Mar. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=121.585+0+-11.309+1.876+-16.223
=96

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥115 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Tianyu Pharmaceutical Co  (SZSE:300702) Pre-Tax Income Explanation

Zhejiang Tianyu Pharmaceutical Co's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=95.929/759.324
=12.63%

During the past 12 years, Zhejiang Tianyu Pharmaceutical Co's highest Pretax Margin was 32.41%. The lowest was -4.14%. And the median was 9.29%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Tianyu Pharmaceutical Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Zhejiang Tianyu Pharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Tianyu Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Chemical Development Zone, Zhejiang Province, Huangyan, Jiangkou, Taizhou, CHN, 318020
Zhejiang Tianyu Pharmaceutical Co Ltd is the pharmaceutical manufacturing company. Its main business is the development, production and sales of active pharmaceutical ingredients and intermediates. The products mainly include antihypertensive drug and intermediates, anti-asthma drug raw materials and intermediates, antiviral drug intermediates. Its products are well sold in domestic and overseas markets.
Executives
Cheng Rong De Directors, executives
Wang Yan Directors, executives
Lin Jie Director
Li Gong Yong Executives
Yang Xiao Song Executives
Fang Hong Jun Directors, executives
Zhu Guo Rong Executives
Zhang Yi Executives
Zhang Jia Liu Executives
Li Mei Jun Executives
Jiang Lu Lu Securities Affairs Representative
Tu Yong Jun Directors, executives

Zhejiang Tianyu Pharmaceutical Co Headlines

No Headlines